baber/WOPTO huggingface dataset:
Patent NZ-549406-A (NZ)
Title: Securing device
Inventor: LUMSDEN WILLIAM JOSEPH
Filed: 2006-08-23
Abstract: A connector for a remotely releasable attachment to an end-fitting of a cable, the connector including: a body including a coupling portion, and a latch moveable between an open and a closed position, the latch being engageable with the end fitting to secure the end-fitting to the connector in the closed position, the latch being biased toward an open position configured to release the end-fitting; characterised in that the connector further includes a moveable keeper member capable of being remotely actuated to engage with the latch by moving between an unlocked and a locked position, respectively permitting and preventing opening of the latch irrespective of fluctuations in tension applied to the latch by the end-fitting.
Patent NZ-554527-A (NZ)
Title: Fluid pump with displaceable partitioning member and cooling element in a sub-chamber, for boiler and heat engine
Inventor: JOHNSTON BARRY WOODS
IPC: F04B43/073
Filed: 2005-10-14
Abstract: A fluid pump for moving a fluid from a first fluid source of the fluid in a low pressure state to a second fluid source of the fluid in a high pressure state, includes a chamber; a partitioning member displaceable in the chamber and dividing the chamber into first and second sub-chambers of varying volumes; the first sub-chamber having an opening controllably communicable with either the second fluid source or a third fluid source; the second sub-chamber having inlet and outlet openings controllably communicable with the first and second fluid sources, respectively; and a cooling element for cooling a fluid in the first sub-chamber.
Patent NZ-560649-A (NZ)
Title: Angiogenic heparin binding peptide amphiphiles, peptide amphiphiles, self-assembled composition and related methods of use
Inventor: STUPP SAMUEL I
IPC: G01N33/53
Filed: 2006-03-06
Abstract: Provides is an amphiphilic peptide compound comprising a hydrophobic component and a peptide component, said hydrophobic component coupled to said peptide component at one of the C-terminus and the N-terminus thereof, said peptide component comprising a sequence selected from LRKKLGKA and LLGARKKK and said hydrophobic component is an alkyl moiety ranging from about six carbons (C6) to twenty-two carbons (C22) in length. The compound can be used to activate angiogenic growth factors.
Patent NZ-562088-A (NZ)
Title: Tobacco packet with moving guide adapter and system comprising tobacco packet and filling machine
Inventor: MINKNER DIRK
Filed: 2007-09-28
Abstract: A tobacco packet 1 for accommodating tobacco for the self-production of cigarettes is disclosed. The tobacco packet has a tobacco dispensing opening, characterised in that a guide adaptor 7 is provided in the region of the tobacco dispensing opening for guiding a movement of the tobacco packet on a complimentary guide of a filling machine.
Patent NZ-566073-A (NZ)
Title: Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
Inventor: MAIER THOMAS
IPC: A61K31/40
Filed: 2006-09-08
Abstract: Disclosed herein are salts of a compound selected from i) (E)-N-hydroxy-3-(1-[4-(([2-(1H-indol-2-yl)-ethyl]-methyl-amino)-methyl)-benzene sulfonyl]-1H-pyrrol-3-yl)-acrylamide, ii) (E)-3-[1-(4-dimethylaminomethyl-benzmesulfonyl)-1H-pyrrol-3-yl]-N-hydroxy-acrylamide, and iii) (E)-N-hydroxy-3-[1-(5-pyridin-2-yl-thiophene-2-sulfonyl)-1H-pyrrol-3-yl]-acrylamide With hydrochloric acid, or a hydrate thereof or a crystalline form of this salt or hydrate. Such compounds are useful inhibitors of histone deacetylases. Also disclosed are combinations comprising said salts as a first active and an amount of at least one secod active compound being an anti-cancer agent selected from the group consisting of chemotherapeutic anti-cancer agents and target-specific anti-cancer agents; and process for preparing crystalline forms the salts of the compounds.
Patent NZ-566508-A (NZ)
Title: Benzimidazole derivatives which have activity at M1 receptor and their uses in medicine
Inventor: BUDZIK BRIAN
IPC: C07D235/26
Filed: 2006-09-27
Abstract: Disclosed is a benzimidazole derivative of the pictured compound, where the substituents are as defined in the specification. Also disclosed is the use of the compound as an muscarinic M1 receptor agonist, and for treating psychotic disorders or cognitive impairments.
Patent NZ-567414-A (NZ)
Title: Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
Inventor: BOCKBRADER HOWARD NORMAN
IPC: A61K31/197
Filed: 2006-10-23
Abstract: Disclosed is a pharmaceutical composition comprising an active pharmaceutical ingredient and excipients, the active pharmaceutical ingredient comprising pregabalin, or a pharmaceutically acceptable complex, salt, solvate or hydrate thereof, and the excipients comprising a matrix forming agent and a swelling agent, the matrix forming agent comprising polyvinyl acetate and polyvinylpyrrolidone, and the swelling agent comprising cross-linked polyvinylpyrrolidone, wherein the pharmaceutical composition is adapted for once-daily oral dosing.
Patent NZ-571791-A (NZ)
Title: Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders
Inventor: EPSTEIN DAVID
IPC: A61K48/00
Filed: 2007-03-08
Abstract: Disclosed is the use of a pegylated or unpegylated aptamer in the preparation of a medicament, wherein: the pegylated or unpegylated aptamer binds to C5 complement; and the medicament is formulated for sequential or substantially simultaneous administration with an anti-VEGF agent and/or anti-PDGF agent, for treating, stabilizing and/or preventing macular degeneration in a subject.
Patent NZ-573464-A (NZ)
Title: An isolated yersinia entomophaga mhp6 bacterium
Inventor: HOLMES MARK ROBIN
IPC: A01N63/20
Filed: 2007-06-08
Abstract: Disclosed is an isolated Yersinia entomophaga MH96 bacterium deposited at DSMZ on 4 May 2006 and designated accession no. DSM 18238. Also disclosed are substances obtained from Yersinia entomophaga MH96, which retain biopesticide activity. Methods for protecting a plant from insect infestation are also disclosed.
Patent NZ-577474-A (NZ)
Title: Azatricyclo[3.3.1.1]decane derivatives and their uses as nicotinic acetylcholine receptors ligands
Inventor: BUNNELLE WILLIAM H
IPC: A61K31/395
Filed: 2007-11-06
Abstract: Disclosed herein is an azaadamantane derivative of formula (I) wherein the substituents are as defined within the specification, specific crystalline salts thereof, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as nicotinic acetylcholine receptor ligands and are therefore useful in the treatment of conditions or disorders such as attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, schizophrenia, age-associated memory impairment (AAMI), senile dementia, AIDS dementia, Pick's disease, dementia associated with Lewy bodies, dementia associated with Down's syndrome, amyotrophic lateral sclerosis, Huntington's disease, smoking cessation, is nicotinic withdrawal syndrome, schizoaffective disorder, bipolar and manic disorders, diminished CNS function associated with traumatic brain injury, acute pain, post-surgical pain, chronic pain, inflammatory pain, and neuropathic pain.
Patent NZ-578099-A (NZ)
Title: Method and apparatus for testing load-bearing capacity utilizing a ring cell
Inventor: HAYES JOHN A
IPC: E02D33/00
Filed: 2007-12-19
Abstract: An annular assembly, or ring cell, is provided for testing the load bearing capacity of piles. The ring cell walls of the annular assembly can be made of stamped material. The ring cell walls can be an outer ring wall and an inner ring wall. Alternately, the ring cell walls can have a 'U'-type shape cross-section including an outer ring wall, an inner ring wall, and a top wall. Fluid can be provided to the annular assembly through fluid supply lines into an expansion zone. The expansion zone can be a space having a bladder for filling with fluid. In another embodiment, the expansion zone can be a space between a filler material capable of withstanding high pressure separated with a membrane. The pressure of the fluid in the expansion zone can be monitored during testing.
Patent NZ-580036-A (NZ)
Title: Wrapped container with label having lines of weakness applied to wrapper with high tack and label applied to container with low tack
Inventor: LUTZIG BODO-WERNER
IPC: B65D5/42
Filed: 2008-05-21
Abstract: A wrapped container has a label (2) attached to the container (1) and to the wrapper. The label (2) comprises at least one line of weakness (3). It is affixed to the wrapper with a high tack connection and is less strongly affixed to the container (1) with a low tack connection such that upon removal of the wrapper the label (2) is at least partially ruptured along the at least one line of weakness (3) and is completely removed from the container (1).
Patent NZ-581314-A (NZ)
Title: Compression garments manufactured with reference to a person's bmi (body mass index)
Inventor: DUFFY BRADLEY THOMAS
IPC: A41D1/08
Filed: 2005-09-23
Abstract: A method of manufacturing a compression garment for clothing a body part of a person, the compression garment including a first panel of material. The method includes the steps of: a) selecting a desired compression to be provided for the body part by the compression garment; b) determining the size of the first panel based on the person's body mass index; and c) manufacturing the garment using the first panel of material so that the garment creates the desired compression in the body part in use.
Patent NZ-583581-A (NZ)
Title: Topical formulation consisting essentially of fipronil and optionally a second active ingredient, and propylene carbonate
Inventor: FREEHAUF KEITH A
IPC: A01N43/00
Filed: 2008-08-29
Abstract: Disclosed is a local topical formulation consisting essentially of fipronil (typically at a concentration of about 10% (w/v)) and optionally a second active ingredient (such as a macrocyclic lactone), and a solvent which is propylene carbonate, for the control of an ectoparasite (such as a flea, tick, fly or louse) on a domestic animal (such as a canine or feline).
Patent NZ-587672-A (NZ)
Title: Intermediates suitable for the synthesis of lactam compounds
Inventor: TANAKA HIDEYUKI
IPC: A61P43/00
Filed: 2006-04-28
Abstract: Disclosed is a compound of formula (1-3), or a salt thereof, wherein R3 and R3' are each hydrogen, nitro, lower alkoxy, halogen, or lower alkyl. Also disclosed is the compound of formula (2-3). Also disclosed is a synthesis of compound (4-3), or a salt thereof, comprising reacting a compound of formula (3-3) with 1,2-diaminocyclohexane.
Patent NZ-591453-A (NZ)
Title: Arrangement for illuminating an aircraft fuselage
Inventor: SIDLER JOANE ANDRE
IPC: B64D47/02
Filed: 2009-01-23
Abstract: 591453 A system for illuminating an image or advertisement on an underside the fuselage of an aircraft. The system has an aerodynamically ergonomic housing mounted to an underside of the fuselage and a light source disposed within the housing to project or emanate light from the light source in an aft direction towards the image or advertisement.
Patent NZ-594709-A (NZ)
Title: Low profile combination lock and latch for sliding cavity door of varying widths
Inventor: SWALES MICHAEL DAVID
IPC: E05B9/00
Filed: 2011-08-19
Abstract: A latch assembly for a sliding cavity door; with the housing being adjustable to fit doors of varying thickness or widths; a latch operator mounted relative to the housing for moving the latch assembly between open and closed positions where the operator is a handle, thumb-turn, privacy barrel, or key lock barrel, a latch drive assembly mounted to rotate within the housing; a slider that is moved linearly by the drive assembly; a latch bolt that is operated by the slider to extend the latch to lock or securely fasten a door in a closed position and retracts to release the door to allow the door to open. The engagement of the slider and latch bolt is adjustable to suit the door thickness.
Patent NZ-596801-A (NZ)
Title: Removal of impurities from lithium-iron disulfide electrochemical cells
Inventor: SCHUBERT MARK A
IPC: H01M4/06
Filed: 2010-06-29
Abstract: A primary electrochemical cell comprises an anode; a cathode including an active material having a maximum potential versus lithium that is less 2.8 volts and a nominal operating voltage of 1.5 volts or less; and a liquid electrolyte comprising a chelating agent capable of sequestering at least one metal ion impurity present within the cell.
Patent NZ-606420-A (NZ)
Title: A hand orthotic and a method of its use
Inventor: WAYNE CHARLES MILICICH
IPC: A61F5/01
Filed: 2013-01-30
Abstract: 606420 An orthosis for use on the hand of a person for training a person in the appropriate ergonomic use of the hand has a hand portion and a finger portion 4 in the form of an open sleeve just for the index finger (and no other fingers) of the person’s hand. The finger portion is partially resistant to movement relative to the hand portion. The hand portion covers a portion of the back of the hand excluding the thumb and the fingers other than the index finger and includes an opening 3 to expose the portion of the palm 7f proximate the second, third and fourth fingers.
Patent NZ-609843-A (NZ)
Title: Wind energy installation having a synchronous generator, and slowly rotating synchronous generator
Inventor: HILDEBRAND ARNO
IPC: H02K9/197
Filed: 2011-10-31
Abstract: A wind energy installation having a synchronous generator which comprises a generator stator and a generator rotor for generating electrical energy. The wind energy installation further comprises a liquid cooling system (300) for cooling the generator rotor (200). The liquid cooling system comprises at least one heat exchanger (310) and at least one cooling passage in the generator rotor (200). The liquid cooling system (300) is configured to rotate with the generator rotor (200).
Patent NZ-614710-A (NZ)
Title: Sustained release of nutrients in vivo
Inventor: VENDRA VENKAT KALYAN
IPC: A23L33/00
Filed: 2009-12-17
Abstract: Disclosed herein is a composition for sustained release of nutrients in vivo comprising: an aqueous suspension, comprising: biologically active agents; and, one or more hydrogel particles that encapsulate one or more nutritional supplements of (a), wherein the one or more hydrogel particles have a diameter between 1 nanometer to 1000 micrometers; comprise one or more compounds that are crosslinked and that release the encapsulated one or more nutritional supplements in a for time controlled and sustained manner release of the nutritional supplements in vivo; and are temperature-responsive, wherein one or more compounds of the hydrogel particles have a lower critical solution temperature in aqueous solution.
Patent NZ-615720-A (NZ)
Title: 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
Inventor: TRABANCO-SUÁREZ ANDRÉS AVELINO
IPC: A61K31/4985
Filed: 2012-03-07
Abstract: Disclosed are 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives of formula I where the substituents are as defined herein. These compounds are inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. Also disclosed are pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer’s disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down’s syndrome, dementia associated with stroke, dementia associated with Parkinson’s disease or dementia associated with beta-amyloid.
Patent NZ-623132-A (NZ)
Title: Resettable drug delivery device
Inventor: JONES CHRISTOPHER
IPC: A61M5/24
Filed: 2010-05-28
Abstract: 623132 Disclosed is a resettable drug delivery device having a resettable dosing mechanism. The dosing mechanism comprises a housing (58) having at least one helical groove, a dose dial sleeve (56) rotationally engaged with the at least one helical groove of the housing, a driver (55) provided within the housing, a first clutch (53/63) provided between the dial sleeve and the driver, and a second clutch (60) between the housing and the driver. When a dose is set (see figure 3) with the dose setting mechanism, the first clutch engages the dose dial sleeve and the driver to rotate together relative to said housing. When the set dose is injected (see figure 5), the first clutch disengages the dose dial sleeve from the driver while the second clutch couples the driver to the housing, so that the dose dial sleeve rotates and the driver is prevented from rotating but moves axially against a spindle (64) to expel the set dose or vice versa. When resetting (see figure 7) the dosing mechanism, the first clutch is operable to decouple the driver from the dose dial sleeve and the second clutch is operable to decouple the driver from the housing, allowing the driver to be moved to a reset position.
Patent NZ-627652-A (NZ)
Title: Apparatus and method for ice making with a mold
Inventor: CHUNG TERRY TAE-II
IPC: F25C1/24
Filed: 2013-01-18
Abstract: A mold (126) defines a first volume for an ice cube, the mold comprising a bottom face (101) having an inner perimeter and side faces (105-108). Each side face has an inner perimeter, top edge (116), and bottom edge (118). The top edge of each side face may be longer than the bottom edge. Each side face may extend inward from the top edge to the bottom edge. The mold may comprise a three-dimensional shape (122) within the first volume, the three- dimensional shape comprising a second volume. The second volume may be defined by a top outer perimeter (103), a bottom outer perimeter (104), and at least two fins of the three-dimensional shape. The fins may extend upwardly and taper between the bottom outer perimeter (104) and the top outer perimeter (103). The mold may further define a third volume between the first and second volumes, with the mold configured to receive water within the third volume.
Patent NZ-702536-A (NZ)
Title: Catalysts
Inventor: VISAGIE JACOBUS LUCAS
IPC: C10G2/00
Filed: 2013-07-26
Abstract: A method of preparing a modified catalyst support comprises preparing a titanium-containing catalyst support material by contacting a catalyst support material with an organic titanium compound. The catalyst support material is selected from the group consisting of (a) a catalyst support precursor comprising an aluminium compound which, upon calcination, converts to a catalyst support in the form of one or more aluminium oxides, and (b) a catalyst support being alumina in the form of one or more aluminium oxides. The organic titanium compound is a titanium compound wherein titanium is associated with at least one organic group by means of a bond. Instead, the catalyst support material can be prepared by co-hydrolysing a hydrolysable organic titanium compound and Al(OR”)3, with the titanium-containing catalyst support material then including Al, wherein all R” are the same or different and are each an organic group. The hydrolysable organic titanium compound is a titanium compound wherein titanium is associated with at least one oxygen atom of at least one organic group by means of a bond. The titanium-containing catalyst support material is calcined at a temperature above 900°C to obtain a modified catalyst support which includes more than 1 wt% and less than 3.5 wt% Ti, based on the weight of the modified catalyst support The Ti is present in the form of one or more titanium compounds.
Patent NZ-703676-A (NZ)
Title: Grid runner to perimeter trim clip
Inventor: GULBRANDSEN PEDER J
IPC: E04B9/30
Filed: 2013-06-24
Abstract: The need for a quick and easy manner of mounting an elongate trim strip on ends of ceiling grid runners is provided by a clip having a right angle configuration with two intersecting legs, one leg adapted to laterally abut an end of a grid runner and the other being adapted to engage the trim strip, said other leg having oppositely extending upper and lower grips for reception into upper and lower opposing channels of the trim strip, the grips being relatively moveable, and a toggle arrangement for moving said grips away from one another, when retracted, the grips being capable of passing between the opposed channels, the toggle arrangement selectively maintaining said grips in an extended position to frictionally lock onto the opposed channels of the trim strip.
Patent NZ-711066-A (NZ)
Title: Processing hydrocarbon-containing materials by irradiation
Inventor: MEDOFF MARSHALL
IPC: C08J11/04
Filed: 2009-10-26
Abstract: Disclosed is a method of processing a hydrocarbon-containing material, the method comprising: irradiating, with an ion beam comprising accelerated charged particles, a combination formed by combining a hydrocarbon-containing material with an inorganic material by dry blending or comminuting to produce an irradiated combination, wherein the hydrocarbon-containing material is selected from the group consisting of: tar sands, oil sands, oil shale, crude oil, bitumen, coal, petroleum gases, liquefied natural gas, synthetic gas, and asphalt; and wherein the inorganic material is selected from the group consisting of a metal, a metal alloy, a metallic compound, a refractory material, and a ceramic.
Patent NZ-711460-A (NZ)
Title: Novel pyrimidine and pyridine compounds and their usage
Inventor: SU WEI-GUO
IPC: C07D239/24
Filed: 2014-03-14
Abstract: The present invention relates to novel pyrimidine and pyridine compounds of formula (I) or a pharmaceutical acceptable salt thereof, wherein R1, R2, R3, R4, R5, X, Y and G are as defined in the description, to pharmaceutical compositions containing them, a process for preparing them, and their use in therapy of a disease responsive to inhibition of FGFR, for example, cancer.
Patent NZ-712389-A (NZ)
Title: Partner snore feature for adjustable bed foundation
Inventor: CHEN YI-CHING
IPC: A47C31/00
Filed: 2014-03-14
Abstract: A sleep system comprises at least one mattress including a first sleep area for a first occupant, the first sleep area including a first section for a portion of a body of the first occupant, and a second sleep area adjacent to the first sleep area for a second occupant, the second sleep area including a second section for a portion of a body of the second occupant, an articulation system for articulating the first section and the second section, a first user controller configured to communicate with the articulation system in order to control articulation of the first section within a first range of articulation positions, and a second user controller configured to communicate with the articulation system in order to control articulation of the second section within a second range of articulation positions, wherein the second range of articulation positions is smaller than the first range of articulation positions and that the controller is configured to allow for full intended control of the articulation of the first section and restricted from articulating the second section to any positions that are outside of the second range of articulation positions.